Related Topics News -

     
 Detail   |   Print    Next page > 
     
綠葉製藥溢價24.9%發行1.8億美元可轉債 擬同步回購2028年到期可轉債
2026-06-04T  
《大行》摩通:美眾議員要求FDA拒絕考慮中國生成臨床數據未寫入撥款法案 建議投資者不要立即採取行動
2026-05-05T  
美國會提案禁採納中國臨床數據
2026-05-04T  
綠葉製藥創新藥LY03015臨床試驗完成首例受試者入組
2026-04-20T  
綠葉製藥LY03017II期臨床試驗完成首例受試者入組
2026-04-15T  
《大行》花旗降綠葉製藥目標價至4.3元 成熟產品降價影響較預期重
2026-04-14T  
綠葉製藥LY03020臨床試驗完成首例受試者入組
2026-04-09T  
《輪動華泰》油價再度走高 電車股留意獨家奇瑞購27386
2026-04-02T  
《業績》綠葉製藥去年純利6.19億元人幣升31.1% 不派末期息
2026-03-31T  
國家藥監局:「十五五」期間將大力支持生物製造產業創新發展
2026-02-04T  
  Next page > 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.